Medical Condition News

RSS

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

Researchers from the University of Oxford have today announced the results of a study into thrombocytopenia (a condition with low platelet counts) and thromboembolic events (blood clots) following vaccination for Covid-19, some of the same events which have led to restricted use of the Oxford-AstraZeneca vaccine in a number of countries.

15 Sep 2021

SARS-CoV-2 can cause sustained biochemical dysregulation that results in long-COVID

This state has come to be known as long-COVID, and in a paper recently uploaded to the preprint server medRxiv* by Simjanoska et al. (September 7th, 2021) the biochemical parameters of long-COVID patients with prior mild, moderate, or severe COVID-19 that resulted in hospitalization are tracked in detail, finding a characteristically dysregulated immune and inflammatory response in the most seriously ill.

15 Sep 2021

New animated video explores how social media affects people with eating disorders

Researchers from Loughborough University have teamed up with UK charity Beat to create an animated video that explores how social media affects people with an eating disorder.

15 Sep 2021

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

Munich-based digital health company Temedica and healthcare company Roche Pharma AG have announced a joint collaboration in the field of digital support for multiple sclerosis patients.

15 Sep 2021

Liver may play a key role in the onset or progression of Alzheimer's disease

Amyloid protein made in the liver can cause neurodegeneration in the brain, according to a new study in the open-access journal PLOS Biology, by John Mamo of Curtin University in Bentley, Australia, and colleagues.

14 Sep 2021

Pregnancy complications with COVID-19

An important new article published in the Clinical Medicine Journal discusses pregnancy complicated with COVID-19.

14 Sep 2021

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines.

14 Sep 2021

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

The hypothesis that raising the brain levels of the natural antioxidant urate could slow the progression of Parkinson's disease (PD) has been disproven by researchers at Massachusetts General Hospital.

14 Sep 2021

Gut microbiome profile could help predict patient's rheumatoid arthritis prognosis

A significant indicator of whether a patient with rheumatoid arthritis will improve over the course of disease may lie in part in their gut, according to new research from Mayo Clinic's Center for Individualized Medicine.

14 Sep 2021

Colorectal Cancer Project launches to improve understanding of the disease and accelerate research

Count Me In, a nonprofit cancer research initiative, is inviting all patients across the United States and Canada who have ever been diagnosed with colorectal cancer to participate in research and help drive new discoveries related to this disease.

14 Sep 2021

New dashboard intends to drive collaborations in cancer and Covid-19 research

The cancer and Covid-19 research dashboard is a public resource that lists research projects looking at the impact of Covid-19 on cancer care and patients.

14 Sep 2021

Researchers explore the impact of venous thromboembolism during surgery for renal cell carcinoma

Venous thromboembolism (VTE) refers to blood clots in the veins, which is a serious yet preventable medical condition and is often seen with advanced cancers.

14 Sep 2021

Cholesterol appears to play a key role in the development of Alzheimer’s disease

Cholesterol manufactured in the brain appears to play a key role in the development of Alzheimer's disease, new research indicates.

14 Sep 2021

IU researcher uncovers potential new approach for treating pancreatic cancer

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified how restoring a missing molecule in pancreatic fibrosis could help deliver treatments to cancer cells.

14 Sep 2021

Researchers discover new pathway that makes drugs less effective in bowel cancer patients

Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer.

14 Sep 2021

Eye conditions linked to increased risk of dementia

Age-related macular degeneration, cataract and diabetes-related eye disease are linked to an increased risk of dementia, suggests research published online in the British Journal of Ophthalmology.

14 Sep 2021

Blood lipid biomarkers associated with lower risk of ALS

Some blood lipid biomarkers linked to cardiovascular disease risk are also associated with a lower risk of amyotrophic lateral sclerosis (ALS) suggest the findings of a large epidemiology study published online in the Journal of Neurology Neurosurgery & Psychiatry.

14 Sep 2021

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Researchers in the UK have conducted a large population-based study showing that people with immune-mediated inflammatory diseases (IMIDs) appear to be at an increased risk of serious outcomes from coronavirus disease 2019 (COVID-19).

14 Sep 2021

Study introduces new surgical procedure to treat patients with congenital intestinal malrotation

A Cleveland Clinic study has introduced a new surgical procedure to treat both children and adults with congenital intestinal malrotation, an inherited disorder that can cause the intestines to twist.

14 Sep 2021

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

In a new study posted to the medRxiv* server scientists from Weil Cornell University and Stony Brook University in New York attempted to identify the metabolic and immune markers associated with severe COVID-19 disease using high-throughput targeted nuclear magnetic resonance (NMR) spectroscopy and high-dimensional flow cytometry. This will facilitate risk stratification, monitoring, and therapeutic interventions in COVID-19 patients.

14 Sep 2021

Medical Condition News

Blood clot risks are high following SARS-CoV-2 infection, not vaccination

SARS-CoV-2 can cause sustained biochemical dysregulation that results in long-COVID

New animated video explores how social media affects people with eating disorders

Temedica and Roche collaborate to provide digital support for multiple sclerosis patients

Liver may play a key role in the onset or progression of Alzheimer's disease

Pregnancy complications with COVID-19

MS patients receiving aCD20 treatment mount robust T-cell responses to COVID-19 vaccines

Researchers disprove natural antioxidant urate for slowing the progression of Parkinson’s disease

Gut microbiome profile could help predict patient's rheumatoid arthritis prognosis

Colorectal Cancer Project launches to improve understanding of the disease and accelerate research

New dashboard intends to drive collaborations in cancer and Covid-19 research

Researchers explore the impact of venous thromboembolism during surgery for renal cell carcinoma

Cholesterol appears to play a key role in the development of Alzheimer’s disease

IU researcher uncovers potential new approach for treating pancreatic cancer

Researchers discover new pathway that makes drugs less effective in bowel cancer patients

Eye conditions linked to increased risk of dementia

Blood lipid biomarkers associated with lower risk of ALS

Immune-mediated inflammatory disease may increase risk of severe COVID-19 outcomes

Study introduces new surgical procedure to treat patients with congenital intestinal malrotation

Metabolic and immune markers as tools for risk stratification and monitoring in COVID-19

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Automation in cell-based workflows

Latest News